Feedback
Alpha-Galactosidase, Serum
2003204
Ordering Recommendation

Enzyme testing is reliable for diagnosing Fabry disease in males; it does not detect carriers. For carrier status, DNA analysis is recommended.

Mnemonic
A GALACTO
Methodology
Quantitative Fluorometry
Performed
Varies
Reported
15-22 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Plain Red or Serum Separator Tube (SST). 
Specimen Preparation
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL) 
Storage/Transport Temperature
Frozen. 
Unacceptable Conditions
Thawed specimens. 
Remarks
 
Stability
Ambient: Unacceptable; Refrigerated: 24 hours; Frozen: 2 weeks 
Reference Interval
By report
Interpretive Data


Note
Results for this assay are not useful for carrier determination. Carriers usually have levels in the normal range.
Components
Component Test Code*Component Chart NameLOINC
2003206Alpha-Galactosidase, Interpretation59462-2
2003211Alpha-Galactosidase, Review59465-5
2003212Alpha-Galactosidase, Serum1813-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Anderson Fabry Disease (Alpha Galactosidase, Serum)
  • GLA Deficiency (Alpha Galactosidase, Serum)
  • Soft AGAS (Alpha Galactosidase, Serum)

Performed at Mayo